4th Quarter - Report

TARPLIN, DOWNS & YOUNG, LLC for NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION (MITA)

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

**see addendum page Free Trade Agreements, offsets and provisions related to medical devices and imaging

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
ISAAC A FORDJOUR —
LINDA E TARPLIN —
JENNIFER B YOUNG —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

**see addendum page PL 111-148 - The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, implementation S. 668 - Health Care Bureaucrats Elimination Act, IPAB H.R. 452 Medicare Decisions Accountability Act of 2011 (IPAB) H.R. 675 - Strengthening Medicare Anti-Fraud Measures Act of 2011 S. 454 - Strengthening Program Integrity and Accountability in Health Care Act of 2011 H.R. 3765/H.R. 3630/H.R. 3743 - Temporary Payroll Tax Cut Continuation Act of 2011, health care provisions ***, no specific bill(s), Medicare Coverage, Regulation and Reimbursement of Imaging Services, Medicare Physician Payment, Sunshine Act

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
ISAAC A FORDJOUR —
LINDA E TARPLIN —
JENNIFER B YOUNG —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 454 (112th), H.R. 3765 (112th), H.R. 675 (112th), H.R. 3630 (112th), H.R. 452 (112th), H.R. 3743 (112th), S. 668 (112th)

Taxation/Internal Revenue Code TAX

PL 111-148 - The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, implementation Device tax repeal bills (S.17/H.R. 436, S. 262/H.R. 734, H.R. 488)

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
ISAAC A FORDJOUR —
LINDA E TARPLIN —
JENNIFER B YOUNG —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Bills named: H.R. 436 (112th), H.R. 488 (112th), H.R. 734 (112th), S. 262 (112th), S. 17 (112th)

Budget/Appropriations BUD

**see addendum page budget resolution, reconciliation, health care reform, debt ceiling negotiations, Joint Select Committee on Deficit Reduction H.R. 2693, S. 365, S. 627 - Budget Control Act of 2011 H.R. 2608, H.R. 2017 - Continuing Appropriations Act of 2012 H.R. 2055 - Consolidated Appropriations Act of 2012

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst.
MICHELLE P EASTON Chief Health Counsel, Sen. Cmte. On Finance;
ISAAC A FORDJOUR —
LINDA E TARPLIN Congressman Billy Tauzin
JENNIFER B YOUNG Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg.

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 2017 (112th), H.R. 2055 (112th), H.R. 2693 (112th), H.R. 2608 (112th), S. 627 (112th), S. 365 (112th)

Health Issues HCR

**see addendum page PL 111-148 - The Patient Protection and Affordable Care Act, implementation FDA User Fee Reauthorizations S. 1700 - The Medical Device Regulatory Improvement Act S. 1865 - Patient Access to Medical Innovation Act S. 1995 Medical Device Patient Safety Act H.R. 3209 - Premarket Predictability Act H.R. 3203 - Novel Device Regulatory Relief Act H.R. 3230 - Keeping America Competitive through Harmonization Act H.R. 3205 - FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 - Humanitarian Device Reform Act H.R. 3208 - Patients Come First Act H.R. 3206 - Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 - Food and Drug Administration Mission Reform Act H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act H.R. 3204 - Guidance Accountability and Transparency Act ***, no specific bill(s), 510k reform, imaging policy, medical device user fee reauthorization

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
ISAAC A FORDJOUR —
LINDA E TARPLIN —
JENNIFER B YOUNG —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1700 (112th), H.R. 3208 (112th), H.R. 3214 (112th), H.R. 3204 (112th), S. 1995 (112th), H.R. 3205 (112th), H.R. 3230 (112th), H.R. 3203 (112th), H.R. 3206 (112th), H.R. 3211 (112th), H.R. 3207 (112th), H.R. 3209 (112th), S. 1865 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.